Hundreds of Victoza cancer lawsuits filed by victims from across the country allege that Victoza, which is an incretin mimetic drug used to treat type 2 diabetes, may cause pancreatic cancer and that the manufacturer of Victoza, Novo Nordisk, failed to warn them of this risk.
Other incretin mimetic drugs have also been linked to this dangerous side effect. As a result, Januvia, Janumet, and Byetta have also been linked to pancreatic cancer. Manufacturers Novo Nordisk, Merck & Co., Eli Lilly, and Amylin Pharmaceuticals now hundreds of lawsuits that have been coordinated for pretrial proceedings in a multidistrict litigation (MDL) in Southern California while further research continues on the question of does Victoza cause pancreatic cancer continues.
If you or a loved one took Victoza were later diagnosed with pancreatic cancer, contact Victoza Cancer Lawyer Timothy L. Miles today for a free case evaluation and see if you are eligible for a Victoza cancer lawsuit and possibly entitled to substantial compensation.
WHAT KIND OF DRUG IS VICTOZA?
Victoza (liraglutide) is a medicine used to treat type 2 diabetes. It is glucagon-like peptide-1 (GLP-1) receptor agonist. A receptor agonist drug means that it binds to a certain receptor and causes the same action as the substance that normally binds to that receptor. Victoza, by binding to and activating the GLP-1 receptor, tells your body to release more insulin, stops the body from releasing more sugar, and slows down digestion.
Victoza is a solution for injection available in pre‑filled pens. The shots are given by the patient once a day by injection under the skin in the abdomen, thigh or upper arm. The starting dose of Victoza is 0.6 mg, and after at least one week, the dose is then increased to 1.2 mg. In certain patients, the dose can be further increased to 1.8 mg one week later, if necessary, achieve better control of blood glucose.
WHAT IS THE PROBLEM WITH VICTOZA?
Incretin mimetic drugs such as Victoza regulate the production of incretin, a type of hormone that stimulates the release of insulin in the body. Victoza does this by injecting patients with a substance that mimics a particular incretin called Glucagon-Like Peptide-1 (GLP-1). Victoza cancer lawsuits allege this process overstimulates the pancreas causing cells in the pancreas to multiply resulting in pancreatic cancer.
Researchers suspect that the process used by Victoza, and other incretin mimetic drugs may overstimulate the pancreas, and in some cases, cause pancreas cells to multiply. One expert in this area, Dr. Peter Butler, who is a diabetes expert at UCLA, discovered a growth of precancerous lesions in the pancreas when this process occurred.
Additionally, according to the U.S. Food & Drug Administration's (FDA) adverse event database, patients taking Januvia, a similar drug to Victoza, are 10 times more likely to be diagnosed with pancreatic cancer. Beyond these observations though, the research is still unclear if and how incretin mimetic drugs cause pancreatic cancer. In 2013, the FDA requested that researchers investigate the correlation in greater detail.
However, as more evidence is gathered for a more detailed review on the question of does Victoza cause pancreatic cancer, patients are continuing to file lawsuits asserting they got pancreatic cancer after taking their type 2 diabetes medication.
In fact, over 2,500 Victoza patients have registered complaints with the FDA also asserting that the medication caused them to have pancreatic side effects. The vast majority (more than 2,300) allege pancreatitis, both acute and chronic. Moreover, similar reports have been made for other incretin mimetics: Roughly 2,400 Januvia patients and more than 3,000 Byetta patients have similarly complained of pancreatitis and filed lawsuits with claims similar to the Victoza cancer lawsuits.
Finally, the American Cancer Society warns that patients with chronic pancreatitis (inflammation of the pancreas) may have an increased risk of developing pancreatic cancer.
If you or a loved one suffered the side effects of Victoza, and were later diagnosed with pancreatic cancer, contact Victoza Cancer Lawyer Timothy L. Miles today and see if you are eligible for a Victoza cancer lawsuit.
WHAT IS THE STATUS OF THE VICTOZA CANCER LAWSUITS?
The Judicial Panel on Multidistrict Litigation (MDL) ordered that 749 incretin mimetic cases filed against leading manufacturers Novo Nordisk, Merck & Co., and Eli Lilly & Co be coordinated for pretrial proceedings in one multi-district litigation (MDL) and transferred the MDL cases to the Southern District of California and assigned to Judge Anthony Battaglia. The Victoza cancer lawsuits, all allege the drugs cause pancreatic cancer and that the manufacturers failed to warn doctors and patients of the risk.
In 2015, Federal Battaglia dismissed the then 744 lawsuits alleging a failure-to-warn in favor of the defendants' argument that the FDA would have prevented them from putting a pancreatic cancer warning on their drug labels, and since the FDA is a federal agency, it overrides state laws.
In September 2016, plaintiffs asserted that Judge Battaglia had misinterpreted federal preemption law. In December 2017, a Ninth Circuit judicial panel agreed, and ruled in favor of plaintiffs, claiming that Judge Battaglia misinterpreted the Supreme Court ruling in Buckman Co. v. Plaintiffs' Legal Committee which states that private parties cannot pursue state law tort claim alleging violations of the Food, Drug, and Cosmetic Act (FDCA). The court of appeals also ruled that consumers claimed defendants violated the common law duty to warn, which falls outside the FDCA.
WHAT DO THE VICTOZA CANCER LAWSUITS ALLLEGE?
The Victoza Cancer Lawsuits allege a combination of the following claims:
HOW DO I KNOW IF I AM ELIGIBLE FOR A VICTOZA CANCER LAWSUIT?
If you or a loved one took Victoza and were diagnosed with pancreatic cancer in 2005 or later, or suffered other serious Victoza side effects, you may be eligible to file a Victoza cancer lawsuit against Novo Nordisk and may be entitled to substantial compensation.
CALL A VICTOZA CANCER LAWYER AND SEE IF YOU ARE ELIGIBLE FOR A VICTOZA CANCER LAWSUIT?
If you or a loved one took Victoza and were diagnosed with pancreatic cancer in 2005 or later, or suffered other serious Victoza side effects you may be eligible for a Victoza cancer lawsuit. Contact Victoza cancer lawyer Timothy L. Miles today and see if you qualify for a Victoza cancer lawsuit and could be eligible for substantial compensation. While there is still time to file a lawsuit, be mindful that these cases are time sensitive, and give us a call today.
TIMOTHY L. MILES, ESQ. Timothy L. Miles is a nationally recognized shareholder and consumer rights attorney raised in Nashville, Tennessee. Mr. Miles was recently selected by Martindale-Hubbell® and ALM as a 2023 Top Ranked Lawyer, 2023 Top Rated Litigator. and a 2023 Elite Lawyer of the South. Mr. Miles also maintains the AV Preeminent Rating by Martindale-Hubbell®, their highest rating for both legal ability and ethics. Mr. Miles is a member of the prestigious Top 100 Civil Plaintiff Trial Lawyers: The National Trial Lawyers Association, a superb rated attorney by Avvo, a recipient of the Lifetime Achievement Award by Premier Lawyers of America (2019) and recognized as a Distinguished Lawyer, Recognizing Excellence in Securities Law, by Lawyers of Distinction (2019). Mr. Miles has published over sixty articles on various issues of the law, including class actions, whistleblower cases, products liability, and more.
The Law Offices of Timothy L. Miles
Tapestry at Brentwood Town Center
300 Centerview Dr., #247
Brentwood, TN 37027
Phone: (855) 846-6529
Email: [email protected]
HOURS OF OPERATION